Northwestern Mutual Wealth Management
CPRX

Northwestern Mutual Wealth Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7K Hold
54
– – ﹤0.01% 3687
2026
Q1 		$1.34K Sell
54
-346
-87% -$8.24K ﹤0.01% 3695
2025
Q4 		$9.34K Buy
400
+225
+129% +$5.01K ﹤0.01% 3018
2025
Q3 		$3.45K Buy
175
+29
+20% +$596 ﹤0.01% 3258
2025
Q2 		$3.17K Buy
+146
New +$3.45K ﹤0.01% 3141
2024
Q4 		– Sell
-133
Closed -$2.64K – 3660
2024
Q3 		$2.64K Buy
+133
New +$2.47K ﹤0.01% 3066
2024
Q2 		– Sell
-3
Closed -$48 – 3545
2024
Q1 		$48 Sell
3
-193
-98% -$2.91K ﹤0.01% 3475
2023
Q4 		$3.29K Buy
+196
New +$2.68K ﹤0.01% 2974
2023
Q1 		– Sell
-252
Closed -$4.69K – 3397
2022
Q4 		$4.69K Buy
252
+250
+12,500% +$3.85K ﹤0.01% 2741
2022
Q3 		$0 Hold
2
– – ﹤0.01% 3163
2022
Q2 		$0 Hold
2
– – ﹤0.01% 3218
2022
Q1 		$0 Buy
+2
New +$14 ﹤0.01% 3148
2021
Q4 		– Sell
-1
Closed – – 3164
2021
Q3 		$0 Buy
+1
New +$5 ﹤0.01% 3040
2018
Q2 		– Sell
-636
Closed -$2K – 2379
2018
Q1 		$2K Buy
+636
New +$2.11K ﹤0.01% 2029
2017
Q4 		– Sell
-500
Closed -$1K – 2317
2017
Q3 		$1K Buy
+500
New +$1.37K ﹤0.01% 2046

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management's CPRX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 54 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3687.

Northwestern Mutual Wealth Management first reported a position in CPRX in Q3 2017 and has held it in 15 quarters since. The position peaked at $9.34K in Q4 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 54 shares of Catalyst Pharmaceutical worth $1.7K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3687 holding.
  • Northwestern Mutual Wealth Management first reported a position in Catalyst Pharmaceutical in Q3 2017 and has held it in 15 quarters since.
  • Northwestern Mutual Wealth Management's Catalyst Pharmaceutical position peaked at $9.34K in Q4 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.